FORA Capital’s Voyager Therapeutics VYGR Stock Holding History

FORA Capital’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,012	Closed	-$51K	–	1017
2020 Q2	$51K	Buy	+4,012	New	+$46.7K	0.02%	644

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FORA Capital's VYGR Position: Q3 2020 in Review

FORA Capital sold out of Voyager Therapeutics (VYGR) in Q3 2020, closing a stake of 4,012 shares — an estimated $51K sold.

FORA Capital first reported a position in VYGR in Q2 2020 and held it in 1 quarter. The position peaked at $51K in Q2 2020. 110 funds tracked by Wall St. Rank hold VYGR as of Q3 2020.

FORA Capital reported no remaining Voyager Therapeutics position as of Q3 2020 after selling out during the quarter.
FORA Capital sold 4,012 Voyager Therapeutics shares in Q3 2020, an estimated $51K.
FORA Capital first reported a position in Voyager Therapeutics in Q2 2020 and held it in 1 quarter.
FORA Capital's Voyager Therapeutics position peaked at $51K in Q2 2020.
110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2020.

Based on FORA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.